vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Duolingo, Inc. (DUOL). Click either name above to swap in a different company.
Duolingo, Inc. is the larger business by last-quarter revenue ($295.5M vs $205.4M, roughly 1.4× COLLEGIUM PHARMACEUTICAL, INC). Duolingo, Inc. runs the higher net margin — 11.9% vs 8.3%, a 3.6% gap on every dollar of revenue. On growth, Duolingo, Inc. posted the faster year-over-year revenue change (27.0% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $103.0M). Over the past eight quarters, Duolingo, Inc.'s revenue compounded faster (28.7% CAGR vs 19.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Duolingo, Inc. is a leading global edtech firm operating a gamified language learning platform. It offers free and premium self-paced courses for over 40 languages, plus language certification, math learning tools, and literacy programs, serving individual learners, schools and corporate clients worldwide.
COLL vs DUOL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $295.5M |
| Net Profit | $17.0M | $35.1M |
| Gross Margin | 62.5% | 55.5% |
| Operating Margin | 29.6% | 8.0% |
| Net Margin | 8.3% | 11.9% |
| Revenue YoY | 12.9% | 27.0% |
| Net Profit YoY | 35.3% | 24.0% |
| EPS (diluted) | $0.48 | $0.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $295.5M | ||
| Q4 25 | $205.4M | $282.9M | ||
| Q3 25 | $209.4M | $271.7M | ||
| Q2 25 | $188.0M | $252.3M | ||
| Q1 25 | $177.8M | $230.7M | ||
| Q4 24 | $181.9M | $209.6M | ||
| Q3 24 | $159.3M | $192.6M | ||
| Q2 24 | $145.3M | $178.3M |
| Q1 26 | — | $35.1M | ||
| Q4 25 | $17.0M | $42.0M | ||
| Q3 25 | $31.5M | $292.2M | ||
| Q2 25 | $12.0M | $44.8M | ||
| Q1 25 | $2.4M | $35.1M | ||
| Q4 24 | $12.5M | $13.9M | ||
| Q3 24 | $9.3M | $23.4M | ||
| Q2 24 | $19.6M | $24.4M |
| Q1 26 | — | 55.5% | ||
| Q4 25 | 62.5% | 72.8% | ||
| Q3 25 | 61.7% | 72.5% | ||
| Q2 25 | 57.7% | 72.4% | ||
| Q1 25 | 54.8% | 71.1% | ||
| Q4 24 | 54.0% | 71.9% | ||
| Q3 24 | 60.8% | 72.9% | ||
| Q2 24 | 62.5% | 73.4% |
| Q1 26 | — | 8.0% | ||
| Q4 25 | 29.6% | 15.4% | ||
| Q3 25 | 29.7% | 12.9% | ||
| Q2 25 | 18.7% | 13.2% | ||
| Q1 25 | 12.2% | 10.2% | ||
| Q4 24 | 20.9% | 6.6% | ||
| Q3 24 | 21.9% | 7.0% | ||
| Q2 24 | 32.7% | 10.5% |
| Q1 26 | — | 11.9% | ||
| Q4 25 | 8.3% | 14.8% | ||
| Q3 25 | 15.0% | 107.5% | ||
| Q2 25 | 6.4% | 17.8% | ||
| Q1 25 | 1.4% | 15.2% | ||
| Q4 24 | 6.9% | 6.6% | ||
| Q3 24 | 5.9% | 12.1% | ||
| Q2 24 | 13.5% | 13.7% |
| Q1 26 | — | $0.72 | ||
| Q4 25 | $0.48 | $0.99 | ||
| Q3 25 | $0.84 | $5.95 | ||
| Q2 25 | $0.34 | $0.91 | ||
| Q1 25 | $0.07 | $0.72 | ||
| Q4 24 | $0.36 | $0.31 | ||
| Q3 24 | $0.27 | $0.49 | ||
| Q2 24 | $0.52 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $1.1B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $1.3B |
| Total Assets | $1.7B | $2.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.1B | ||
| Q4 25 | $386.7M | $1.0B | ||
| Q3 25 | $285.9M | $1.0B | ||
| Q2 25 | $222.2M | $976.2M | ||
| Q1 25 | $197.8M | $884.0M | ||
| Q4 24 | $162.8M | $785.8M | ||
| Q3 24 | $120.0M | $854.4M | ||
| Q2 24 | $271.6M | $888.2M |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $301.7M | $1.3B | ||
| Q3 25 | $274.8M | $1.3B | ||
| Q2 25 | $232.2M | $977.0M | ||
| Q1 25 | $234.4M | $893.8M | ||
| Q4 24 | $228.8M | $824.5M | ||
| Q3 24 | $234.3M | $822.5M | ||
| Q2 24 | $216.6M | $766.9M |
| Q1 26 | — | $2.0B | ||
| Q4 25 | $1.7B | $2.0B | ||
| Q3 25 | $1.6B | $1.9B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.1B | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $105.6M |
| Free Cash FlowOCF − Capex | $122.4M | $103.0M |
| FCF MarginFCF / Revenue | 59.6% | 34.9% |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $368.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $105.6M | ||
| Q4 25 | $123.0M | $107.3M | ||
| Q3 25 | $78.4M | $84.2M | ||
| Q2 25 | $72.4M | $90.7M | ||
| Q1 25 | $55.4M | $105.6M | ||
| Q4 24 | $84.6M | $83.3M | ||
| Q3 24 | $-9.0M | $56.3M | ||
| Q2 24 | $67.4M | $62.4M |
| Q1 26 | — | $103.0M | ||
| Q4 25 | $122.4M | $96.6M | ||
| Q3 25 | $78.3M | $79.4M | ||
| Q2 25 | $72.4M | $89.5M | ||
| Q1 25 | $54.6M | $104.3M | ||
| Q4 24 | $84.1M | $81.4M | ||
| Q3 24 | $-9.2M | $53.1M | ||
| Q2 24 | $67.1M | $56.8M |
| Q1 26 | — | 34.9% | ||
| Q4 25 | 59.6% | 34.1% | ||
| Q3 25 | 37.4% | 29.2% | ||
| Q2 25 | 38.5% | 35.5% | ||
| Q1 25 | 30.7% | 45.2% | ||
| Q4 24 | 46.2% | 38.8% | ||
| Q3 24 | -5.8% | 27.6% | ||
| Q2 24 | 46.2% | 31.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 3.8% | ||
| Q3 25 | 0.1% | 1.8% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.3% | 0.9% | ||
| Q3 24 | 0.2% | 1.7% | ||
| Q2 24 | 0.2% | 3.1% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 7.25× | 2.56× | ||
| Q3 25 | 2.49× | 0.29× | ||
| Q2 25 | 6.05× | 2.02× | ||
| Q1 25 | 22.92× | 3.01× | ||
| Q4 24 | 6.75× | 5.99× | ||
| Q3 24 | -0.96× | 2.41× | ||
| Q2 24 | 3.44× | 2.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
DUOL
| Bookings | $283.5M | 96% |
| Other | $12.0M | 4% |
